Enhance Genetics Body Building
New posts

77860

  1. E

    FDA grants orphan drug status to NBI-77860 for treatment of congenital adrenal hyperplasia

    FDA grants orphan drug status to NBI-77860 for treatment of congenital adrenal hyperplasia Neurocrine Biosciences, Inc. announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor antagonist, has been granted orphan drug status by the United States Food and...
    • EGBOT
    • Thread
    • 77860 congenital orphan status treatment
    • Replies: 0
    • Forum: News
Back
Top